{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:05:13Z","timestamp":1775617513531,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf02614227","type":"journal-article","created":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T04:21:40Z","timestamp":1177993300000},"page":"89-97","source":"Crossref","is-referenced-by-count":7,"title":["Experience of the treatment with Sehydrin (Hydrazine Sulfate, HS) in the advanced cancer patients"],"prefix":"10.1007","volume":"13","author":[{"given":"Vladimir A.","family":"Filov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michail L.","family":"Gershanovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia A.","family":"Danova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris A.","family":"Ivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02614227_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000225043","volume":"32","author":"J Gold","year":"1975","unstructured":"Gold J: Use of hydrazine sulfate in terminal and pre-terminal cancer patients: results of investigational new drug study in 84 evaluated patients Oncology 32:1\u201310 1975","journal-title":"Oncology"},{"key":"BF02614227_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/01635587909513640","volume":"4","author":"J Gold","year":"1979","unstructured":"Gold J: Hydrazine sulfate and cancer cachexia. Nutrition and Cancer I: n4, 4\u20139 1979.","journal-title":"Nutrition and Cancer I"},{"key":"BF02614227_CR3","first-page":"959","volume":"60","author":"HJ Lerner","year":"1976","unstructured":"Lerner HJ, Regelson W: Clinical trial of hydrazine sulfate in solid tumours. Cancer Treat Rep 60:959\u2013960 1976","journal-title":"Cancer Treat Rep"},{"key":"BF02614227_CR4","first-page":"1151","volume":"59","author":"M Ochoa","year":"1975","unstructured":"Ochoa M, Wittes RE, Krakoff IH: Trial of hydrazine sulfate in patients with cancer. Cancer Chemother Rep Part I 59:1151\u20131154 1975","journal-title":"Cancer Chemother Rep Part I"},{"key":"BF02614227_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00254983","volume":"3","author":"E Spremulli","year":"1979","unstructured":"Spremulli E, Wampler GL, Regelson W: Clinical study of hydrazine sulfate in advanced cancer patients. Cancer Chemother Pharmacol 3:121\u2013124 1979.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF02614227_CR6","first-page":"243","volume":"16","author":"SB Strum","year":"1975","unstructured":"Strum SB, Bierman HR, Thompson R: Hydrazine sulfate in patients with neoplasia. Proc Amer Assoc Cancer Res and Amer Soc Clin Oncol 16:243 1975","journal-title":"Proc Amer Assoc Cancer Res and Amer Soc Clin Oncol"},{"key":"BF02614227_CR7","first-page":"964","volume":"60","author":"J Gold","year":"1976","unstructured":"Gold J: Hydrazine sulfate in the treatment of cancer. Cancer Treat Rep 60:964\u2013965 1976","journal-title":"Cancer Treat Rep"},{"key":"BF02614227_CR8","first-page":"437","volume":"4","author":"J Gold","year":"1978","unstructured":"Gold J: Method of treating cancerous cachexia in humans with hydrazine sulfate. US Patent 4:110, 437, 1978","journal-title":"US Patent"},{"issue":"n. 1","key":"BF02614227_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/01635588109513695","volume":"3","author":"J Gold","year":"1981","unstructured":"Gold J: Anabolic profiles in late-stage cancer patients responsive in hydrazine sulfate. Nutrition and Cancer 3: n. 1, 13\u201319 1981","journal-title":"Nutrition and Cancer"},{"key":"BF02614227_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO;2-W","volume":"59","author":"RT Chlebowski","year":"1987","unstructured":"Chlebowski RT, Bulcavage L, Grosvenor M, Tsunokai R, Block JB, Heber D, Scrooc M, Chlebowski JS, Jocelchi J, Oktay E, Akman S, Ali I: Hydrazine sulfate in cancer patients with weight loss. Cancer 59:406\u2013410 1987","journal-title":"Cancer"},{"key":"BF02614227_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1200\/JCO.1990.8.1.9","volume":"8","author":"RT Chlebowski","year":"1990","unstructured":"Chlebowski RT, Bulcavage L, Grosvenor M, Oktay E, Block JB, Chlebowski JS, Ali I, Elaskoff R: Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. J Clin Oncol 8:9\u201315 1990.","journal-title":"J Clin Oncol"},{"key":"BF02614227_CR12","first-page":"203","volume":"2","author":"VA Filov","year":"1978","unstructured":"Filov VA, Stukov AN, Blank MA, Neischtadt EL Experimental data on the toxic action of hydrazine sulfate on the organism and tumour. Farmakologia i Toksikologia (Rus) 2:203\u2013205 1978","journal-title":"Farmakologia i Toksikologia (Rus)"},{"issue":"n. 1","key":"BF02614227_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/01635588109513694","volume":"3","author":"ML Gershanovich","year":"1981","unstructured":"Gershanovich ML, Danova LA, Ivin BA, Filov VA: Results of clinical study of antitumour action of hydrazine sulfate. Nutrition and Cancer 3:n. 1, 7\u201312 1981","journal-title":"Nutrition and Cancer"},{"key":"BF02614227_CR14","first-page":"933","volume":"60","author":"ML Gershanovich","year":"1976","unstructured":"Gershanovich ML, Danova LA, Kondratyev VB, Malyugina LL, Stukov AN, Seitz JF, Filov VA: Clinical data on the antitumour activity of hydrazine sulfate. Cancer Treat Rep 60:933\u2013935 1976","journal-title":"Cancer Treat Rep"},{"key":"BF02614227_CR15","first-page":"45","volume":"I","author":"IF Seitz","year":"1975","unstructured":"Seitz IF, Gershanovich ML, Filov VA, Danova LA, Kondratyev VB, Maljugina LL, Muller NR, Polkina VF, Rudakov VG, Stukov AN. Experimental and clinical data on antitumour action of hydrazine sulfate. Voprosy Oncologii (Rus) I:45\u201352 1975","journal-title":"Voprosy Oncologii (Rus)"},{"key":"BF02614227_CR16","first-page":"45","volume":"8","author":"LA Danova","year":"1977","unstructured":"Danova LA, Kondratyev VB, Gershanovich ML, Filov VA: The results of hydrazine sulfate administration in lymphogranulomatosis. Terapevticheski Arkhiv (Rus) 8:45\u201347 1977","journal-title":"Terapevticheski Arkhiv (Rus)"},{"key":"BF02614227_CR17","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1200\/JCO.1994.12.6.1113","volume":"12","author":"MP Kosty","year":"1994","unstructured":"Kosty MP, Fleischman SB, Herndon II JE, Coughlin K, Kornblith AB, Scalzo A, Morris JC, Mortimer J, Green MR: Cisplatin, vinblastine, and hydrazine sulfate in advanced non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the cancer and leukemia group B. J Clin Oncol 12:1113\u20131120 1994","journal-title":"J Clin Oncol"},{"key":"BF02614227_CR18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1200\/JCO.1994.12.6.1126","volume":"12","author":"ChL Loprinzi","year":"1994","unstructured":"Loprinzi ChL, Goldberg RW, Su JQ, Mailliard JA, Kurross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, Wender DB, Burch PA: Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol 12: 1126\u20131129 1994","journal-title":"J Clin Oncol"},{"key":"BF02614227_CR19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.1994.12.6.1121","volume":"12","author":"ChL Loprinzi","year":"1992","unstructured":"Loprinzi ChL, Kurross SA, O\u2019Fallon JR, Gesme DH, Gerstner JB, Rospond RM, Cobau ChD, Goldberg RM: Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol 12:1121\u20131125 1992","journal-title":"J Clin Oncol"},{"key":"BF02614227_CR20","unstructured":"Filov VA, Danova LA, Gershanovich ML, Tretjakov AV, Ivin BA. Hydrazine sulfate: experimental and clinical data, mechanisms of action. In: Drug Therapy of Tumours in Experiments and Clinic. Leningrad (Rus), 91\u2013139, 1983"},{"key":"BF02614227_CR21","first-page":"100","volume":"6","author":"AV Tretjakov","year":"1979","unstructured":"Tretjakov AV, Filov VA, Ryazanov AS, Tarkov AS: Experimental data on hydrazine sulfate antitumour action. Voprosy Onkologii (Rus) 6:100\u2013103 1979","journal-title":"Voprosy Onkologii (Rus)"},{"key":"BF02614227_CR22","first-page":"6","volume":"2","author":"MD Mashkovsky","year":"1980","unstructured":"Mashkovsky MD, Andreyeva NI, Polezhaeva AI: MAO inhibitors as a drug therapy. Khim-Pharm J (Rus) 2:6\u201312 1980","journal-title":"Khim-Pharm J (Rus)"},{"key":"BF02614227_CR23","first-page":"72","volume":"6","author":"EA Baumanis","year":"1981","unstructured":"Baumanis EA: Search for anticarcinogenic agents among regulators of aminooxydase activity. Izvestia of the Latvian Academy of Sci (Rus) 6:72\u201386 1981","journal-title":"Izvestia of the Latvian Academy of Sci (Rus)"},{"key":"BF02614227_CR24","first-page":"14","volume":"5","author":"IG Veksler","year":"1983","unstructured":"Veksler IG: Psychotropic drugs and their role in combined drug therapy of malignant neoplasms. Experimentalnaya Onkologia (Rus) 5:14\u201320 1983","journal-title":"Experimentalnaya Onkologia (Rus)"},{"key":"BF02614227_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1749-6632.1974.tb14440.x","volume":"30","author":"J Gold","year":"1974","unstructured":"Gold J: Cancer cachexia and gluconeogenesis. Ann N Y Acad Sci 30:103\u2013110 1974","journal-title":"Ann N Y Acad Sci"},{"key":"BF02614227_CR26","first-page":"71","volume":"7","author":"VS Misheneva","year":"1980","unstructured":"Misheneva VS, Burova TM, Goryukhina TA: The influence of hydrazine sulfate on the activity of phosphoenolpyruvate-carboxykinase and the growth of experimental tumours. Voprosy Oncologii (Rus) 7:71\u201373 1980","journal-title":"Voprosy Oncologii (Rus)"},{"key":"BF02614227_CR27","first-page":"73","volume":"I","author":"VA Filov","year":"1984","unstructured":"Filov VA, Burova TM: Gluconeogenesis in hydrazine sulfate treatment of animals with experimental tumours. Bull of Exper Biol Med (Rus) I:73\u201374 1984","journal-title":"Bull of Exper Biol Med (Rus)"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02614227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02614227\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02614227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02614227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:49:40Z","timestamp":1678556980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02614227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF02614227"],"URL":"https:\/\/doi.org\/10.1007\/bf02614227","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}